MVM Life Science Partners is a venture capital firm specializing in investments in start-up, early stage, mid venture, late venture.
MVM was founded in 1997 and manages four funds totalling more than US$700 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 31, 2017
VitalConnect
|
Series C | $38M | Biotechnology | Yes |